The Effect of Glucagon on the Blood Glucose Level and the Clinical State in the Presence of Marked Insulin Hypoglycemia

Department of Psychiatry of The Johns Hopkins Hospital, Baltimore, Md.

This investigation, under the direction of Dr. John C. Whitehorn, was supported by a research grant (M-1085) from the National Institute of Mental Health of the National Institutes of Health, Public Health Service.

The glucagon employed in this study was kindly supplied by Dr. W. R. Kirtley of Eli Lilly and Company. Portions of lots numbered 208-158B-214, 208-158B-214A, and 258-234B-30A were included.

Find articles by Schulman, J. in: PubMed | Google Scholar

Department of Psychiatry of The Johns Hopkins Hospital, Baltimore, Md.

This investigation, under the direction of Dr. John C. Whitehorn, was supported by a research grant (M-1085) from the National Institute of Mental Health of the National Institutes of Health, Public Health Service.

The glucagon employed in this study was kindly supplied by Dr. W. R. Kirtley of Eli Lilly and Company. Portions of lots numbered 208-158B-214, 208-158B-214A, and 258-234B-30A were included.

Find articles by Greben, S. in: PubMed | Google Scholar